Prostate Stones: Why They Often Resist Treatment

Prostatic calculi—small, often asymptomatic calcifications within the prostate gland—are frequently detected incidentally during imaging studies such as transrectal ultrasound or CT scans. While they may raise concern among patients, these stones are generally benign and do not require treatment in the vast majority of cases.

Unlike urinary tract stones, prostatic calculi rarely cause obstruction, infection, or significant lower urinary tract symptoms. They typically form due to chronic inflammation, ductal obstruction, or metabolic changes within prostatic secretions—not from systemic mineral imbalances. Importantly, there is no evidence that prostatic calculi progress to malignancy or directly impair prostate function.

Current urological guidelines, including those from the American Urological Association (AUA) and European Association of Urology (EAU), do not recommend routine intervention for asymptomatic prostatic calculi. Surgical removal is neither feasible nor indicated, as the stones are embedded within glandular tissue and not freely mobile within a cavity. Attempts at lithotripsy or endoscopic extraction carry substantial risk of complications—including bleeding, infection, and iatrogenic damage to surrounding structures—without proven clinical benefit.

In rare instances where calculi are associated with recurrent prostatitis or persistent, refractory symptoms, management focuses on addressing the underlying inflammatory or infectious process—not the stones themselves. Antibiotics, anti-inflammatory agents, or alpha-blockers may be considered based on clinical presentation, but stone removal remains contraindicated.

Patients diagnosed with prostatic calculi should be reassured that these findings are common—especially with advancing age—and are not a sign of disease progression or treatment failure. Routine follow-up is unnecessary unless new or worsening genitourinary symptoms develop.